Pharmaceuticals

Latest KFF 国产精品视频 News Stories

What鈥檚 Keeping the US From Allowing Better Sunscreens?

KFF 国产精品视频 News Original

A decade after Congress told the FDA to expedite the approval of more effective sunscreens, the federal government still has not approved sunscreen ingredients that are safely being used around the world. Meanwhile, skin cancer is the nation鈥檚 most common cancer.

KFF 国产精品视频 News' 'What the 国产精品视频?': Abortion Access Changing Again in Florida and Arizona

Podcast

A six-week abortion ban took effect in Florida this week, dramatically restricting access to the procedure not just in the nation鈥檚 third-most-populous state but across the South. Patients from states with even more restrictive bans had been flooding in since the overturn of Roe v. Wade in 2022. Meanwhile, the CEO of the health behemoth United国产精品视频 Group appeared before committees in both the House and Senate, where lawmakers grilled him about the February cyberattack on subsidiary Change 国产精品视频care and how its ramifications are being felt months later. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Rachana Pradhan of KFF 国产精品视频 News join KFF 国产精品视频 News鈥 Julie Rovner to discuss these stories and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.

To Stop Fentanyl Deaths in Philadelphia, Knocking on Doors and Handing Out Overdose Kits

KFF 国产精品视频 News Original

Facing widening racial disparities in overdose deaths, Philadelphia officials are sending workers and volunteers to knock on doors across the city, aiming to equip households with naloxone and other drug overdose prevention supplies. City officials hope a proactive approach will normalize naloxone as an everyday item in people鈥檚 medicine cabinets and prevent overdoses, especially among Black residents.

KFF 国产精品视频 News' 'What the 国产精品视频?': The Supreme Court and the Abortion Pill

Podcast

The Supreme Court this week heard its first abortion case since overturning Roe v. Wade in 2022, about an appeals court ruling that would dramatically restrict the availability of the abortion pill mifepristone. But while it seems likely that this case could be dismissed on a technicality, abortion opponents have more challenges in the pipeline. Meanwhile, health issues are heating up on the campaign trail, as Republicans continue to take aim at Medicare, Medicaid, and the Affordable Care Act 鈥 all things Democrats are delighted to defend. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Lauren Weber of The Washington Post join KFF 国产精品视频 News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KFF 国产精品视频 News鈥 Tony Leys, who wrote a KFF 国产精品视频 News-NPR 鈥淏ill of the Month鈥 feature about Medicare and a very expensive air-ambulance ride. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.

This State Isn鈥檛 Waiting for Biden To Negotiate Drug Prices

KFF 国产精品视频 News Original

As the federal government negotiates with drugmakers to lower the price of 10 expensive drugs for Medicare patients, impatient legislators in some states are trying to go even further. Leading the pack is Colorado, where a new Prescription Drug Affordability Review Board is set to recommend an 鈥渦pper payment limit鈥 for drugs it deems unaffordable. In late […]

KFF 国产精品视频 News' 'What the 国产精品视频?': The ACA Turns 14

Podcast

Saturday marks the 14th anniversary of the still somewhat embattled Affordable Care Act. 国产精品视频 and Human Services Secretary Xavier Becerra joins host Julie Rovner to discuss the accomplishments of the health law 鈥 and the challenges it still faces. Also this week, Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Mary Agnes Carey of KFF 国产精品视频 News join Rovner to discuss what should be the final funding bill for HHS for fiscal 2024, next week鈥檚 Supreme Court oral arguments in a case challenging abortion medication, and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.

A Battle Between Drugmakers and Insurers Hits Patients in the Wallet

KFF 国产精品视频 News Original

There鈥檚 a long-running battle between insurers and drugmakers over financial assistance programs that purport to help patients afford expensive drugs. And lately, insurers have been losing ground as lawmakers, regulators and courts weigh in. The issue is whether coupons and other copay aid many patients get from drugmakers should count toward annual insurance deductibles and […]